{"disease":{"id":"castleman-s-disease-multicentric","name":"castleman s disease multicentric"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07085039","title":"Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":14,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03933904","title":"Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7,"lead_sponsor_name":"University of Pennsylvania","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}